The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71 (2), Page

Similar documents
Effect of intravenous contrast medium administration on prostate diffusion-weighted imaging

11/10/2015. Prostate cancer in the U.S. Multi-parametric MRI of Prostate Diagnosis and Treatment Planning. NIH estimates for 2015.

Keywords Prostate, cancer, magnetic resonance imaging (MRI), diffusion-weighted imaging (DWI), Gleason score

Prostate MRI. Overview. Introduction 2/20/2015. Prostate cancer is most frequently diagnosed noncutaneous cancer in males (25%)

The diagnosis and localization of prostate cancer are based on a digital

Diffusion Weighted Imaging in Prostate Cancer

MR-US Fusion Guided Biopsy: Is it fulfilling expectations?

The role of T2-weighted imaging in detecting prostate cancer of the central zone in 3T multiparametric magnetic resonance examination

Stephen McManus, MD David Levi, MD

Problems: TRUS Bx. Clinical questions in PCa. Objectives. Jelle Barentsz. Prostate MR Center of Excellence.

Can Diffusion-Weighted Magnetic Resonance Imaging Predict a High Gleason Score of Prostate Cancer?

Department of Urology, II Clinic, Ankara Numune Education and Research Hospital, Ankara, Turkey 2

Diffusion-Weighted Magnetic Resonance Imaging for the Evaluation of Prostate Cancer: Optimal B Value at 3T

PI-RADS classification: prognostic value for prostate cancer grading

Whole-tumor apparent diffusion coefficient measurements in nephroblastoma: Can it identify blastemal predominance? Abstract Purpose To explore the

Genitourinary Imaging Original Research

Diffusion-Weighted Imaging of Prostate Cancer

Shayan Sirat Maheen Anwar, 1 Zahid Anwar Khan, 2 Rana Shoaib Hamid, 3 Fahd Haroon, 4 Raza Sayani, 1 Madiha Beg, 1 and Yasir Jamil Khattak 1

Contribution of prostate-specific antigen density in the prediction of prostate cancer: Does prostate volume matter?

MRI-targeted, transrectal ultrasound-guided prostate biopsy for suspected prostate malignancy: A pictorial review

PCa Commentary. Executive Summary: The "PCa risk increased directly with increasing phi values."

Correlated diffusion imaging

Diffusion weighted MRI in evaluation of transplanted kidney: Preliminary clinical experience

Effects of Post Biopsy Digital Rectal Compression on Improving Prostate Cancer Staging Using Magnetic Resonance Imaging in Localized Prostate Cancer

Prostate Cancer MRI. Accurate Diagnosis and Treatment. PSA to Prostate MRI. for patients and curious doctors

The follow-up of uterine fibroids treated with HIFU: role of DWI and Dynamic contrast-study MRI

TRUS Guided Transrectal Prostate Biopsy

10/2/2018 OBJECTIVES PROSTATE HEALTH BACKGROUND THE PROSTATE HEALTH INDEX PHI*: BETTER PROSTATE CANCER DETECTION

Anatomic Imaging of Prostate Cancer

Multiparametric MRI diagnostic value in a case of prostate cancer

DTI fiber tracking at 3T MR using b-1000 value in the depiction of periprostatic nerve before and after nervesparing prostatectomy

MOLECULAR MEDICINE REPORTS 9: , Provincial Hospital, Shandong University, Jinan , P.R. China

Cancer. Description. Section: Surgery Effective Date: October 15, 2016 Subsection: Original Policy Date: September 9, 2011 Subject:

Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer

Genitourinary Imaging Original Research

PROSTATE MRI. Dr. Margaret Gallegos Radiologist Santa Fe Imaging

بسم هللا الرحمن الرحيم. Prof soha Talaat

How to detect and investigate Prostate Cancer before TRT

The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA

Supplemental Information

Prostate Cancer DFP Case of the Week

Prostate MRI for local staging and surgical planning in prostate cancer

1 Uniform hyperintense signal intensity (normal). 2 Linear (arrow), wedge-shaped, or diffuse mild hypointensity, usually indistinct margin.

Diffusion-Weighted Magnetic Resonance Imaging Detects Local Recurrence After Radical Prostatectomy: Initial Experience

Apparent Diffusion Coefficient for Prostate Cancer Imaging: Impact of b Values

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

Yahui Peng, PhD 2 Yulei Jiang, PhD Tatjana Antic, MD Maryellen L. Giger, PhD Scott E. Eggener, MD Aytekin Oto, MD. Purpose: Materials and Methods:

Prostate MRI Hamidreza Abdi, MD,FEBU Post Doctoral Fellow Vancouver Prostate Centre UBC Department of Urologic Sciences May-20144

Detection of prostate cancer by MR-ultrasound fusion guided biopsy

A Comparison of Different Imaging Techniques for Localisation of Cancers in the Prostate

Utility of ADC Measurements in the Discrimination between Benign and Lymphomatous Abdomino-Pelvic Lymph Nodes

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

Current Clinical Practice. MR Imaging Evaluations. MRI Anatomic Review. Imaging to Address Clinical Challenges. Prostate MR

Prostate MRI: Not So Difficult. Neil M. Rofsky, MD, FACR, FSCBTMR, FISMRM Dallas, TX

Screening and Risk Stratification of Men for Prostate Cancer Metastasis and Mortality

Accuracy of Multiparametric MRI for Prostate Cancer Detection: A Meta-Analysis

Hospital, University of Bologna, Bologna, Italy. Department of Urology, University of Bologna, Sant Orsola-Malpighi Hospital, Bologna, Italy

OASIS 1.2T: MULTIPARAMETRIC MRI OF PROSTATE CANCER

Essentials of Clinical MR, 2 nd edition. 73. Urinary Bladder and Male Pelvis

High-Resolution Diffusion-Weighted Imaging of the Prostate

Prostate Overview Quiz

Improved Detection of Clinically Significant Prostate Cancer Using a Structured Prostate Imaging Reporting Data System (PI-RADS) Template

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Research Article Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer

Can diffusion weighted imaging distinguish between benign and malignant solid or predominantly solid gynecological adnexal masses?

Additional value of Diffusion Weighted Imaging in the detection and treatment of prostate cancer

Genitourinary Imaging Original Research

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Role of MRI Diffusion in Assessment of Mediastinal Lymphadenopathy

JMSCR Vol 05 Issue 03 Page March 2017

Optimizing Implementation of Prostate MRI. Andrei S Purysko, M.D. Section of Abdominal Imaging & Nuclear Radiology Department

Essential Initial Activities and Clinical Outcomes

I have no financial relationships to disclose. I WILL NOT include discussion of investigational or off-label use of a product in my presentation.

Genitourinary Imaging Original Research

Prostate MRI: Access to and Current Practice of Prostate MRI in the United States

Role of MRI Apparent Diffusion Coefficient Quantification in the Differentiation between Benign and Malignant Mediastinal and Pulmonary Lesions

The Impact of MRI-TRUS Cognitively Targeted Biopsy on the Incidence of Pathologic Upgrading After Radical Prostatectomy

Prostate Cancer Local or distant recurrence?

Recently, prostate-specific antigen (PSA) has been identified as a

Prostate MRI: Who needs it?

Role of Conventional and Diffusion Weighted MRI in the Evaluation of Pediatric Musculoskeletal Tumors

Intrahepatic cholangiocarcinoma: diffusion-weighted MR imaging findings

Focus on... Prostate Health Index (PHI) Proven To Outperform Traditional PSA Screening In Predicting Clinically Significant Prostate Cancer

PI-RADS version 2 - what we need to know

Int J Clin Exp Med 2016;9(2): /ISSN: /IJCEM Dong Yang 1, Nan Jin 2, Yan Guo 3, Huan-Jun Wang 3, Bi-Tao Pan 3

Differentiation of Noncancerous Tissue and Cancer Lesions by Apparent Diffusion Coefficient Values in Transition and Peripheral Zones of the Prostate

Multiparametric 3T MR imaging of the prostate - acquisition protocols and image evaluation

Multi-parametric MRI (MP-MRI) in prostate- Experience and Technical Challenges

Prostate tumour volumes: evaluation of the agreement between magnetic resonance imaging and histology using novel co-registration software

MRI in the Enhanced Detection of Prostate Cancer: What Urologists Need to Know

Magnetic resonance imaging predictors of extracapsular extension of prostate cancer: Do they accurately reflect pt3 staging?

FieldStrength. Multi-parametric 3.0T MRI provides excellent prostate imaging

The role of apparent diffusion coefficient (ADC) and relative ADC in the evaluation of breast masses

Prostate Cancer 3/15/2017. CEUS of the Prostate. The Prostate Cancer Screening Dilemma Data. Incidence: 161,360 Deaths: 26,730

Detection of Prostate Cancer from Multiparametric Magnetic Resonance Imaging

Genitourinary Imaging Original Research

Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

PI-RADS V2 IN PRACTICE A PICTORIAL REVIEW

Transcription:

The Egyptian Journal of Hospital Medicine (April 2018) Vol. 71 (2), Page 2490-2497 Role of ADC Map MR Imaging in Prediction of Local Aggressiveness of Prostate Cancer Asaad Gamal Asaad Sorial, Omar Farouk Kamel, Mohsen Gomaa Hassan Ismail Radiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt Corresponding author: Asaad Gamal Asaad Sorial, Mobile: +201024134310, E-mail: asaad.gamal@gmail.com ABSTRACT Objective: of this study is to evaluate the relationship between ADC map values of MR imaging and local aggressiveness of the prostate Cancer via comparing the ADC values and Gleason score in prostate Cancer. Methodology: this study carried out in Radiology Department of Ain Shams University Hospitals. 21 patients with pathologically proven prostate cancer underwent pelvic MRI examination including diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC). Result: The mean ADC value is inversely related to Gleason Score. Keywords: prostate cancer (PCA), Gleason score (GS), apparent diffusion coefficient (ADC), transrectal ultrasound (TRUS). INTRODUCTION Prostate cancer is the most commonly diagnosed solid malignant tumor among men. The morbidity and mortality directly attributable to this common malignancy are significant. However, in a non-negligible proportion of patients, the disease may be considered relatively indolent [1]. The diagnosis of prostate cancer is based on a digital rectal examination (DRE) and assessment of serum prostate specific antigen (PSA) followed by transrectal ultrasound (TRUS)-guided biopsy [2]. T2-weighted MRI has been commonly used to detect prostate cancer. Recently, diffusion-weighted MRI (DW-MRI) has been widely introduced in the clinical setting. It is beneficial as it offers increased diagnostic accuracy due to the clear delineation between normal and prostate cancer, namely the high signal of cancerous lesions. DW-MRI is a noninvasive imaging technique that quantifies the diffusion of water molecules in tissues without any contrast agents, tracers, or exposure to radiation. DW-MRI may also provide qualitative information regarding the pathophysiological character of prostate cancer [3]. The assessment of local aggressiveness of prostate cancer (PCa) is of key importance for appropriate management of this disease. The increase in life expectancy of the general population combined with efficient screening methods will lead to an increase in the number of new PCa cases. These cases will tend to be more localized and at an earlier stage [4]. The Gleason scoring (GS) system has been accepted internationally as a reference grading system for prostate cancer with respect to tumor aggressiveness, tumors are classified as low risk (Gleason score, 6), intermediate risk(gleason score, 7) or high risk (Gleason score, 8) [5]. To establish the ADC as a strong biomarker for predicting prostate cancer Gleason scores, standardization of quantitative ADC metrics is of crucial importance [6]. AIM OF WORK The objective of this study is to evaluate the relationship between ADC map values of MR imaging and local aggressiveness of the prostate cancer via comparing the ADC values and Gleason score in prostate cancer. PATIENTS AND METHODS Patients During a period of 6 months duration from August 2017, twenty-one patients were enrolled in the study. All patients with elevated prostatic specific antigen (PSA) values greater than 4 ng/ml underwent sextant TRUS guided biopsies. MRI examination was done either prior to the TRUS biopsy or at least 3 weeks after the TRUS biopsy. The study was approved by the Ethics Board of Ain Shams University. 2490 Received: 22/ 1/2018 DOI: 10.12816/0045646 Accepted:2 / 2 /2018

Role of ADC Map MR Imaging Inclusion criteria Histopathologically (biopsy) proven prostate cancer. No age predilection. Exclusion criteria Patients having contraindication to MRI. Histopathologically proven cases of benign lesions. Patients with pathologically proven prostate cancer and the lesion is not detected by MRI. Histopathological Analysis The histology was reviewed by an experienced pathologist. MRI imaging Conventional MRI and DWIs were performed using Philips achieva XR 1.5-T system using a torso XL 16 channels phased array coil. Diffusion study DW images were acquired in the axial plane using the single-shot echo-planar imaging technique. Diffusion-encoding gradients were applied using three b values of 0,600 and 800 s/mm 2 along the three orthogonal directions of motion-probing gradients. ADC maps were automatically constructed on a pixel by-pixel basis. MRI data analysis Region of interest (ROI) was drawn on the ADC maps on the visualized tumor, and if multiple tumors were present the average ADC value was recorded for each lesion. When the ROI was drawn, attention was paid to the exclusion of the neurovascular bundle and urethra to minimize any error in the Calculation of the ADC. Statistical analysis Data were coded and entered using the statistical package SPSS (Statistical Package for the Social Sciences) version 23. Data were summarized using mean, standard deviation, median, minimum and maximum in quantitative data and using frequency (count) and relative frequency (percentage) for categorical data. Comparisons between quantitative variables were done using the non-parametric Kruskal-Wallis and Mann- Whitney tests. ROC curve was constructed with area under curve analysis performed to detect best cutoff value of ADC for detection of the grade of cancer prostate. P-values less than 0.05 were considered as statistically significant. RESULTS The 21 patients enrolled in this study were ranging from 64 to 85 years with mean age of 73.4 years. The total PSA was elevated ranging from 7.6 to 905.5 in all patients. Table (1) Demonstrating the PSA and age of the patients Mean Standard Deviation Median Minimum Maximum PSA 100.1 168.05 35.70 7.6 905.50 Age 73.4 7.14 75.00 64.00 85.00 Regarding the histopathological type of the diagnosed prostate cancer patients, all had adenocarcinoma. 90.47 % of the lesions were located in the peripheral zone, 14.3 % were located in the central zone and 4.76 % were located in the transitional zone (9.5% of the lesions were located in both the peripheral and central zones). 90.5% of the lesions were localized by thet2wis. In about 9.5% the lesions were not well identified by the T2WI. 2491

Asaad Sorial et al. T2 90.5% 9.5 % Negative Positive Percentage of positive DWI in localization of prostate cancer 120% 100% 80% 60% 40% 20% 0% Positive Negative Positive Negative Positive Negative T2 Bright DWI Dark ADC Figure (1): Pie chart demonstrating percentage of positive T2 in localization of prostate cancer Localization of the lesions was then confirmed by the DWI where the lesions appeared bright in 95.2% of them. In only 4.8% restriction was not clear among the rest of the prostatic tissue and the lesions were identified by the dark signal in the ADC map. Bright signal in DWI Positive 4.80% Figure (3): Chart demonstrating the difference between T2, DWI and ADC map images in localization of the lesions. Regarding the Gleason scores;2 of the cases had Gleason score (3+3),5 had Gleason score (3+4),4 had Gleason score (4+3), 5had Gleason score (4+4),2had Gleason score (4+5), 2had Gleason score (5+4) and 1 had Gleason score (5+5). The mean ADC and standard deviation is calculated for each different group. Negative 95.20 % Figure (2): Pie chart demonstrating Table (2) Demonstrating the mean ADC value and the standard deviation of each Gleason score MEAN ADC Gleason Score 3+3 3+4 4+3 4+4 4+5 5+4 5+5 Mean 0.926 0.814 0.782 0.765 0.709 0.680 0.630 SD ±0.005 ±0.006 ±0.001 ±0.004 ±0.001 ±0.002 The mean ADC decreases as the Gleason score increases with a significant p value <0.001 P value <0.001 2492

mean ADC Role of ADC Map MR Imaging 1 0.8 0.6 0.4 0.2 0 MEAN ADC 3+3 3+4 4+3 4+4 4+5 5+4 5+5 Gleason Score MEAN ADC 0.92 0.81 0.78 0.76 0.71 0.68 0.63 Figure (4) demonstrating the relationship between the mean ADC value and the Gleason score A B C Figure (5) cancer prostate in a 73 year old male patient with total PSA 12.4 ng/ml and Gleason score 3+4 A- Axial T2 weighted images showing low signal intensity lesion seen in central zone and left part of peripheral zone. B- DWI (at b value 600) showing bright signal intensity of the lesion. C- ADC map images showing low signal intensity of the lesion with mean ADC value 0.810 A B C D Figure (6) cancer prostate in a 79 year old male patient with total PSA 50.6 ng/ml and Gleason score 4+4 A and B Axial and coronal T2 weighted images showing left peripheral zone low signal intensity lesion with extra capsular extension. C- DWI (at b value 600) showing bright signal intensity of the lesion. D- ADC map image showing low signal intensity of the lesion with mean ADC value 0.77. Tumors were then classified as low risk (Gleason score, 6), intermediate risk(gleason score, 7) or high risk (Gleason score, 8) and the mean ADC value and the standard deviation were calculated for each group. 2493

Asaad Sorial et al. Table (3) Demonstrating the mean ADC value and the standard deviation of different grades of the tumor. MEAN ADC GS 6 7 8-10 Mean 0.926 0.799 0.724 Standard Deviation ±0.006 ±0.017 ±0.049 We found that the mean ADC decreases as the Gleason score increase which helps as to discriminate between low grade (Gleason score 6), intermediate grade (Gleason score 7) and high grade (Gleason score 8-10) prostate cancer with a significant p value < 0.001 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0 low grade intermediate grade high grade GS MEAN ADC Figure (7) Demonstrating the relationship between the mean ADC value and the grade of the tumor. But we found that the mean ADC of Gleason score (4+3) was lower than that of Gleason score (3+4) which means that tumors with Gleason score (4+3) was more aggressive than that of Gleason score (3+4). Table (4) Demonstrating the difference between the mean ADC value and the standard deviation of Gleason score 3+4 and Gleason score 4+3 MEAN ADC Gleason Score 3+4 4+3 Mean 0.814 0.782 Standard Deviation ±0.006 ±0.001 P value 0.001 2494

Role of ADC Map MR Imaging Figure (8) Chart demonstrating the relation chip between the mean ADC value and Gleason scores 3+4 and 4+3 ROC analysis was done for ADC cut off value as a marker for identification of high and low grade tumors and showed a significant p value < 0.001. The cut off value for GS >7 was < 0.7725 and for GS < 7 was > 0.8620 with AUC (area under the curve) in both 100% and with sensitivity and specificity of 100% Table (5) Demonstrating the results of the ROC for Gleason score >7 Area under curve P value 95% Confidence Interval Lower Bound Upper Bound Cutoff value Sensitivity (%) Specificity (%) 1.000 <0.001 1.000 1.000 0.7725 100 100 Table (6) Demonstrating the results of the ROC for Gleason score <7 Area under curve P value 95% Confidence Interval Lower Bound Upper Bound Cutoff value Sensitivity (%) Specificity (%) 1.000 <0.001 1.000 1.000 0.8620 100 100 DISCUSSION Within the prostate, the predominant contribution of DW MR imaging signal is from the extracellular component (from tubular structures and their fluid content), with a lesser contribution from the extracellular stromal space and the intracellular components (epithelial and stromal cells). Because of the abundant self-diffusion of water molecules within the predominant tubular components within the peripheral zone, their contents provide a high signal on ADC maps [7]. With increasing Gleason grade, the change in tissue organization to a more solid and compact architecture (with higher cellular density) should be reflected in restrictions in the distances of free water motion within the tissue. Well-differentiated prostate carcinomas display tubular formation with a concomitant higher contribution of unrestricted water motion to ADCs. Lower-grade tumors are also known to have a remarkable heterogeneity in glandular size and the ability to grow between pre-existing ducts. Conversely, poorly differentiated adenocarcinomas show more expansile masses of small, tightly packed cell groups with small-to-absent lumina [8]. 2495

Asaad Sorial et al. In our study there are about 9.5 % of the cases the lesions are not well identified by T2 and in about 4.8 % the lesions are not well identified by DWI. We agreed with the previous results obtained by Tan et al. [9] (2011)in the limitation of T2 in TZ tumors and limitation of DWI in both TZ tumors and prostatic base tumors. On T2WI, the peripheral zone (PZ) is distinctly separate from the transitional zone (TZ), which would theoretically include the anatomic central zone as well. It is accepted that tumor detection by T2WI in the transitional zone (TZ) is inferior to that in the PZ. The PZ is predominantly composed of glandular tissue that is hyperintense on T2WI and contrasts well with tumor. In comparison, the TZ contains more stromal tissue, giving rise to lower T2 signal which may overlap with tumor. Diffusion-weighted imaging may improve MRI detection of TZ tumors. However, as with T2WI, DWI sensitivity for tumor in the TZ remains less than in the PZ. Evaluation of tumors in prostatic base by DWI can be limited by increased cellularity in the normal prostatic base [9]. The results of this study showed that mean ADC values are negatively correlated with GS with a significant p value <0.001. The relationship between the mean ADC values and the GS in the previous studies was summarized by Caivano et al. [10] in Table 7. (Table 7) Published data on Gleason Score (GS) and ADC Values (Caivano et al.). [10] ADC value [mean + SD (mm2/s)] and GS Studies N 4+4 3+4 3+3 Field strength (T ) Kagebayashi et al. 30 0.77± 0.2 0.77± 0.2 1.14± 0.4 1.5 Oto et al. 70 1.3±/ none 1.7±/ 1.5 Ibrahiem et al. 68 none 1.045± 0.336 none 1.5 Woodfield et al. 57 0.672 ± 0.057 0.702± 0.03 0.86± 0.036 1.5 Nagarajan et al. 44 0.831± 0.087 0.976± 0.103 1.135± 0.119 1.5 Hambrock et al. 51 0.68 ± 0.13 0.97± 0.22 1.36± 0.26 3 Doo et al. 51 0.779 ± 0.171 0.779 ±0.171 0.875± 0.131 3 Somford et al. 23 0.86 ± 0.21 none 1.16 ± 0.19 3 Caivano etal. 40 0.916 ± 0.072 1.104 ± 0.122 1.193 ±0.094 3 Substantial agreement has been found among our results and all these findings. In our study ROC analysis for ADC cut off value as a marker for identification of high and low grade tumors showed a significant p value < 0.001. The cut off value for GS > 7 was < 0.7725 and for GS < 7 was > 0.8620 with AUC in both 100% (may be due to limited sample size)and with sensitivity and specificity of 100% (may be due to limited sample size). Nowak et al. [11] who performed their study in 104 cancers calculated ADC cutoff values for different criteria for maximum values of both sensitivity(90.5%) and specificity (62.5%), ADC values lower than 1.005 x 10-3 mm 2 /s indicated a GS 7, for high sensitivity (95.2%) and specificity of50%, the cutoff ADC value for GS>7 was 1.052x10-3 mm 2 /s and ADC of >0.762 X10-3 mm 2 /s indicated rather a 3+4 type Gleason grade with an AUC of 69.6%, corresponding to a sensitivity and specificity of 77.5% and 64.7% respectively. Our results also showed that the mean ADC value might be able to separate PCA with a GS of 7 into the subgroups of 3+4=7 and 4+3=7 cancers. There was a statistically significant difference between ADC values in patients with GS4+3 and those with GS 3+4 prostate cancers. Patients with GS 4+3 had lower ADC values when compared to those with GS 3+4 and there were statistically significant differences between the ADC values of the two groups (P<0.001).This is consistent with the studies of Itou et al.,verma et al., Caivano et al. and Nowak et al. [10-13], who agreed that the mean values of Gleason grade 3+4 cancers were significantly 2496

Role of ADC Map MR Imaging different from those of the reference category of 4+3 cancers. SUMMARY AND CONCLUSION Carcinoma of the prostate is an important health problem. It is the most frequently diagnosed solid malignant tumor among men. DW MRI in the prostate is a relative new and increasingly used imaging technique. It has the advantage that it can be obtained during a single breath-hold, as well as lack of use of contrast media. The ADC maps can provide quantitative measurements of tissue water diffusivity through ADC values, which can be used for many applications including assessment of prostate cancer aggressiveness. This study suggests that ADC values may allow the non invasive assessment of biological aggressiveness of prostate cancer, which may contribute in planning initial treatment strategies. In conclusion, quantitative DW MR imaging may be a noninvasive biomarker that is well suited for determining prostate cancer aggressiveness. The mean ADC value is inversely related to Gleason Score. REFERENCES 1. De Cobelli F, Ravelli S, Esposito A et al. (2015): Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.ajr Am J Roentgenol., 204(3):550-557. 2. Anwar S, Anwar K, Shoaib H et al.(2014): Assessment of apparent diffusion coefficient values as predictor of aggressiveness in peripheral zone prostate cancer: comparison with Gleason score. ISRN radiology,. 2014:263417 3. Bae H, Yoshida S, Matsuoka Y et al.(2014): Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer. International urology and nephrology, 46:. 555-561 4. Lebovici A, Sfrangeu S, Feier D et al.(2014): Evaluation of the normal-todiseased apparent diffusion coefficient ratio as an indicator of prostate cancer. 1 imaging, 14: aggressiveness.bmc medical 5. Doo K, Sung D, Park B et al.(2012): Delectability of low and intermediate or high risk prostate cancer with combined T2- weighted and diffusion-weighted MRI. Eur Radiol.,22:1812 1819 6. Donati O, Mazaheri Y, Afaq A et al.(2014): Prostate Cancer Aggressiveness: Assessment with Whole-Lesion Histogram Analysis of the Apparent Diffusion Coefficient. Radiology,271(1):143-152 7. Tamada T, Sone T, Jo Y et al.(2008): Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. Radiology, 248 (2): 531 539. 8. Hambrock T, Somford D, Huisman H et al.(2011): Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology,259(2):453 461. 9. Tan C, Wang J, and Kundra V (2011): Diffusion weighted imaging in prostate. 593-603 radiology, 21.3: cancer. European 10. Caivano R, Rabasco P, Lotumolo A et al.(2013): Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer. 625-629 investigation, 31: patients. Cancer 11. Nowak J, Malzahn U, Baur A et al.(2014): The value of ADC, T2 signal intensity and a combination of both parameters to assess Gleason score and primry Gleason grades in patients with known prostate cancer. Acta Radiol.,57(1):107-114. 12. Itou Y, Nakanishi K, Narumi Y et al.(2011): Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer? Journal of. 167-172 Imaging, 33: Magnetic Resonance 13. Verma S, Rajesh A, Morales H et al.(2011): Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. Am J Roentgenol., 196:374 381. 2497